The Favaloro Foundation First in South America to Preserve & Transport Donor Heart with Paragonix

  • Post author:
  • Post category:News

CAMBRIDGE, Massachusetts & Buenos Aires, Argentina---Paragonix Technologies, Inc. today announced that the Paragonix SherpaPak™ Cardiac Transport System (CTS), the industry’s only FDA cleared and CE marked system for donor heart transport…

Continue ReadingThe Favaloro Foundation First in South America to Preserve & Transport Donor Heart with Paragonix

Paragonix SherpaPak™ Cardiac Transport System to be Featured in Clinical Presentation at 2019 American Transplant Congress

  • Post author:
  • Post category:News

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. today announced that the Paragonix SherpaPak™ Cardiac Transport System (CTS), the industry’s only FDA cleared and CE marked system for donor organ heart transport and storage, will be featured in a clinical presentation at the 2019 American Transplant Congress. The meeting is being held June 1-5, 2019 in Boston.

Continue ReadingParagonix SherpaPak™ Cardiac Transport System to be Featured in Clinical Presentation at 2019 American Transplant Congress

Paragonix Announces Transplanted-Cost Savings & Clinical Results for Donor Heart Preservation using SherpaPak Cardiac Transport System in Routine & Complex Heart Transplantation

  • Post author:
  • Post category:News

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. today announced clinical results presented during the Paragonix SherpaPak™ CTS 2019 International Heart Summit held during the International Society for Heart and Lung Transplantation (ISHLT) 2019 Annual Meeting in Orlando, FL. Five U.S. and European Centers shared clinical use experiences of the Paragonix SherpaPak™ Cardiac Transport System (CTS) for the preservation of donor hearts destined for heart transplantation.

Continue ReadingParagonix Announces Transplanted-Cost Savings & Clinical Results for Donor Heart Preservation using SherpaPak Cardiac Transport System in Routine & Complex Heart Transplantation

Paragonix & the Lung Transplant Foundation Announce Expansion of Partnership to Accelerate Commercialization of Innovative Lung Preservation Technologies

  • Post author:
  • Post category:News

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Paragonix Technologies Inc., and the Lung Transplant Foundation (LTF) today announced an expansion of their partnership for the development of a series of innovative technologies for improved donor lung preservation.At a…

Continue ReadingParagonix & the Lung Transplant Foundation Announce Expansion of Partnership to Accelerate Commercialization of Innovative Lung Preservation Technologies

Paragonix Initiates Global Post Market Registry Evaluating Clinical Outcomes in Patients who Receive Donor Hearts Transported with Paragonix SherpaPak™ Cardiac Transport System

  • Post author:
  • Post category:News

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Paragonix Technologies, Inc. today announced the opening of the Global Utilization And Registry Database for Improved heArt preservatioN (“GUARDIAN”) post-market registry, which will assess clinical outcomes when employing the Paragonix…

Continue ReadingParagonix Initiates Global Post Market Registry Evaluating Clinical Outcomes in Patients who Receive Donor Hearts Transported with Paragonix SherpaPak™ Cardiac Transport System

Paragonix SherpaPak Cardiac Transport System to be Demonstrated at the International Society for Heart and Lung Transplantation 2019 Annual Meeting

  • Post author:
  • Post category:News

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Paragonix Technologies, Inc. today announced that it will be exhibiting at the International Society for Heart and Lung Transportation (ISHLT) 2019 Annual Meeting, from April 3rd to 5th at the Loews Meeting Complex in Orlando, Florida.

Continue ReadingParagonix SherpaPak Cardiac Transport System to be Demonstrated at the International Society for Heart and Lung Transplantation 2019 Annual Meeting